We first enrolled all lung cancer cases (n = 483 for LUAD; n = 486 for LUSC) as the “Tumor” group and observed a higher expression level of SNRPA in the “Tumor” group, compared with the “Control” group (Figure 1A). Here, SNRPA is linked to lung carcinoma.